Literature DB >> 19856217

Recurrence and regrowth of benign meningiomas.

Satoshi Nakasu1, Tadateru Fukami, Jyunya Jito, Kazuhiko Nozaki.   

Abstract

The World Health Organization (WHO) grading system for meningioma is helpful for predicting aggressive subtypes. However, even benign meningiomas sometimes show relatively rapid growth and may recur after total removal. We attempted to find histopathological features that would be valuable for predicting recurrence or regrowth of WHO grade I meningiomas. We investigated 135 benign meningiomas, of which 120 were totally removed (Simpson's grade I-III). The median follow-up period was 9.7 years (1-21 years). The recurrence rate in the patients with total removal was 7.5% at 10 years and 9.3% at 20 years. The univariate analysis revealed that MIB-1 index (>or=2%), existence of mitosis, absence of calcification, and paucity of fibrosis significantly correlated with recurrence. On the other hand, the histological features of sheet-like growth, prominent nucleoli, and necrosis did not correlate with recurrence, because they were relatively rare in grade I tumors. Multivariate analysis revealed that high MIB-1 index and absence of calcification significantly correlated with recurrence. The patients with recurrent or residual tumors did not always receive adjuvant treatment. Including subtotally treated tumors, the retreatment rate was 9.8% at 10 years and 25.6% at 20 years. MIB-1 index and Simpson's grade significantly correlated with retreatment in both univariate and multivariate analyses.

Entities:  

Mesh:

Year:  2009        PMID: 19856217     DOI: 10.1007/s10014-009-0251-2

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  21 in total

1.  A qualitative assessment of the supportive care and resource needs of patients undergoing craniotomy for benign brain tumours.

Authors:  Janice Wong; Daniel Mendelsohn; Joyce Nyhof-Young; Mark Bernstein
Journal:  Support Care Cancer       Date:  2010-10-27       Impact factor: 3.603

2.  Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.

Authors:  Camila Batista de Oliveira Silva; Bárbara Roberta Ongaratti; Geraldine Trott; Taiana Haag; Nelson Pires Ferreira; Carolina Garcia Soares Leães; Julia Fernanda Semmelmann Pereira-Lima; Miriam da Costa Oliveira
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Comparative Proteomic Profiling Using Two-Dimensional Gel Electrophoresis and Identification via LC-MS/MS Reveals Novel Protein Biomarkers to Identify Aggressive Subtypes of WHO Grade I Meningioma.

Authors:  Joshua W Osbun; Philip D Tatman; Sumanpreet Kaur; Carolina Parada; Tina Busald; Luis Gonzalez-Cuyar; Min Shi; Donald E Born; Jing Zhang; Manuel Ferreira
Journal:  J Neurol Surg B Skull Base       Date:  2017-04-26

Review 4.  Olfactory groove meningiomas: a retrospective study on 59 surgical cases.

Authors:  Alexandru Vlad Ciurea; Stefan Mircea Iencean; Radu Eugen Rizea; Felix Mircea Brehar
Journal:  Neurosurg Rev       Date:  2011-09-30       Impact factor: 3.042

5.  Anatomic location is a risk factor for atypical and malignant meningiomas.

Authors:  Ari J Kane; Michael E Sughrue; Martin J Rutkowski; Gopal Shangari; Shanna Fang; Michael W McDermott; Mitchel S Berger; Andrew T Parsa
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

Review 6.  Pathological classification and molecular genetics of meningiomas.

Authors:  Christian Mawrin; Arie Perry
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

7.  Periostin: a novel prognostic predictor for meningiomas.

Authors:  Yi Liu; Jin Shi; Ming Chen; Yong-fu Cao; Ya-wei Liu; Jun Pan; Song-tao Qi
Journal:  J Neurooncol       Date:  2014-12-18       Impact factor: 4.130

Review 8.  Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.

Authors:  P D Delgado-López; E M Corrales-García
Journal:  Clin Transl Oncol       Date:  2020-07-10       Impact factor: 3.405

9.  Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma.

Authors:  Shirin Karimi; Manav V Vyas; Lior Gonen; Raha Tabasinejad; Quinn T Ostrom; Jill Barnholtz-Sloan; Suganth Suppiah; Gelareh Zadeh; Kenneth Aldape
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

10.  The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring.

Authors:  Conor S Gillespie; Abdurrahman I Islim; Basel A Taweel; Christopher P Millward; Siddhant Kumar; Nitika Rathi; Shaveta Mehta; Brian J Haylock; Nicola Thorp; Catherine E Gilkes; David D A Lawson; Samantha J Mills; Emmanuel Chavredakis; Jibril Osman Farah; Andrew R Brodbelt; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2021-04-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.